Location: Bend, OR
CIK: 0001440771 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 10, 2022
Total Value: $222M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AMRYT PHARMA PLC - SPNR ADR | 6,227,733 | $43.1M | 19.4% | $12.42 | — | SPONSORED ADS | 03217L106 |
| QDEL | QUIDELORTHO CORP | 501,633 | $35.86M | 16.1% | $92.45 | -3.2% | COM | 219798105 |
| — | CTI BIOPHARMA CORP | 5,669,388 | $33M | 14.8% | $3.66 | — | COM | 12648L601 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 12,928,168 | $20.17M | 9.1% | $2.15 | -22.9% | COM | 98422E103 |
| — | APOLLO ENDOSURGERY INC | 2,832,631 | $15.61M | 7.0% | $5.33 | — | COM | 03767D108 |
| ADMA | ADMA BIOLOGICS INC | 5,000,000 | $12.15M | 5.5% | $1.31 | +82.5% | COM | 000899104 |
| URGN | UROGEN PHARMA LTD | 1,124,220 | $9.354M | 4.2% | $7.11 | +16.4% | COM | M96088105 |
| — | AMARIN CORP PLC -ADR | 8,547,965 | $9.317M | 4.2% | $2.49 | — | SPONS ADR NEW | 023111206 |
| LGND | LIGAND PHARMACEUTICALS | 99,562 | $8.573M | 3.9% | $68.37 | -14.0% | COM NEW | 53220K504 |
| RZLT | REZOLUTE INC | 2,973,205 | $8.147M | 3.7% | $3.95 | -26.9% | COM NEW | 76200L309 |
| — | OPTINOSE INC | 2,000,000 | $7.32M | 3.3% | $1.62 | — | COM | 68404V100 |
| — | AFFIMED NV | 1,979,828 | $4.078M | 1.8% | $2.77 | — | COM | N01045108 |
| XGN | EXAGEN INC | 1,265,373 | $3.429M | 1.5% | $11.52 | -51.6% | COM | 30068X103 |
| — | CONFORMIS INC | 17,304,350 | $3.309M | 1.5% | $0.75 | — | COM | 20717E101 |
| OVID | OVID THERAPEUTICS INC | 1,540,671 | $2.835M | 1.3% | $3.43 | -39.0% | COM | 690469101 |
| ATYR | ATYR PHARMA INC | 600,980 | $1.803M | 0.8% | $6.39 | -47.6% | COM NEW | 002120202 |
| — | OPIANT PHARMACEUTICALS INC | 152,278 | $1.637M | 0.7% | $11.99 | — | COM | 683750103 |
| EOLS | EVOLUS INC | 200,000 | $1.61M | 0.7% | $10.60 | 0.0% | COM | 30052C107 |
| XOMA | XOMA CORP | 64,459 | $1.154M | 0.5% | $20.39 | +1.1% | COM NEW | 98419J206 |